You are here

Media Coverage

September 29, 2016
SF Business Times

Ten years after their discovery, Shinya Yamanaka’s induced pluripotent stem, or IPS, cells are spinning potential treatments into companies.


August 6, 2016
Washington Post

In response to the NIH's decision to explore funding chimera research, Sheng Ding comments in the Washington Post that scientists should be cautious and move slowly when considering human-animal stem cell research.

August 1, 2016
The Scientist

Katherine Pollard writes for The Scientist about the parts of the genome that make us uniquely human. These pieces of DNA, called "Human Accelerated Regions," evolved rapidly from our chimpanzee ancestors and helped us develop bigger brains and opposable thumbs.


July 15, 2016

Leor Weinberger and his brother Ariel have teamed up to fight viruses like HIV and Zika. They are using mutant forms of the viruses to co-evolve, interfere, and ultimately overwhelm the deadly infections.

July 5, 2016
Scientific American

Gladstone senior investigator Shinya Yamanaka says Dolly the sheep told him that nuclear reprogramming was possible in mammalian cells and inspired him to begin developing stem cells derived from adult cells—an accomplishment that won him a Nobel Prize in 2012.

June 22, 2016
SF Chronicle

Scientists have had profound success in treating and preventing HIV, turning what was once an almost-certain death sentence into a chronic illness. However, Gladstone Insitute of Virology and Immunology director, Warner Greene, says that a vaccine is still the Holy Grail in HIV research.

June 15, 2016

Induced pluripotent stem cells were supposed to herald a medical revolution. But ten years after their discovery, they are transforming biological research instead. Nature reviews Shinya Yamanaka's groundbreaking discovery and the remarkable progress made since.

June 15, 2016

Ways to directly convert one mature cell type into another may eventually offer a safer, faster strategy for regenerative medicine. Deepak Srivastava and Sheng Ding are leading the charge to advance cellular reprogramming and bring the technology to the clinic.

Scientists from opposite ends of the translational spectrum have teamed up to help solve a pressing problem in Alzheimer’s research. By creating a human equivalent to the water mazes used in rodent studies, they hope to allow easier comparison of data from animal and human studies.

June 7, 2016

Katherine Pollard comments on the “game-changing” microbial research of Pieter Dorrestein at UC San Diego. Dorrestein is using mass spectrometry to eavesdrop on the molecular conversations between microbes and their world.